Penumbra (PEN) Capital Expenditures Growth (1y) (2015 - 2026)
Penumbra (PEN) Capital Expenditures Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -43.42% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -11.95% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 27.22% |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | 1.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.51% |
| Dec 31, 2025 | 126.90% |
| Sep 30, 2025 | -604.49% |
| Jun 30, 2025 | 243.45% |
| Mar 31, 2025 | 131.23% |
| Dec 31, 2024 | -34.00% |
| Sep 30, 2024 | -46.03% |
| Jun 30, 2024 | 286.97% |
| Mar 31, 2024 | 49.56% |
| Dec 31, 2023 | -391.58% |
| Sep 30, 2023 | 59.11% |
| Jun 30, 2023 | -154.75% |
| Mar 31, 2023 | -21.44% |
| Dec 31, 2022 | -78.20% |
| Sep 30, 2022 | 143.87% |
| Jun 30, 2022 | 8,421.15% |
| Mar 31, 2022 | 126.97% |
| Dec 31, 2021 | 14,955.45% |
| Sep 30, 2021 | 116.98% |
| Jun 30, 2021 | -99.23% |